D68.318
Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
HCC risk adjustment mapping
CMS-HCC ESRD V24
Coagulation Defects and Other Specified Hematological Disorders
Coding notes
Excludes 1 never coded together · Excludes 2 may co-exist
Antithromboplastinemia Antithromboplastinogenemia Hemorrhagic disorder due to intrinsic increase in antithrombin Hemorrhagic disorder due to intrinsic increase in anti-VIIIa Hemorrhagic disorder due to intrinsic increase in anti-IXa Hemorrhagic disorder due to intrinsic increase in anti-XIa
autoimmune disease (systemic) NOS (M35.9) certain conditions originating in the perinatal period (P00-P96) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) human immunodeficiency virus [HIV] disease (B20) injury, poisoning and certain other consequences of external causes (S00-T88) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)
Official Guidelines for D68.318
FY 2026 ›Find D68.318 in the alphabetic index
9 index paths lead to this code
- Anticoagulant, circulating
- Antithromboplastinemia
- Antithromboplastinogenemia
- Circulating anticoagulants
- Disorder › hemorrhagic NEC › due to › intrinsic › circulating anticoagulants
- Disorder › hemorrhagic NEC › due to › intrinsic › increase in › antithrombin
- Disorder › hemorrhagic NEC › due to › intrinsic › increase in › anti-VIIIa
- Disorder › hemorrhagic NEC › due to › intrinsic › increase in › anti-IXa
- Disorder › hemorrhagic NEC › due to › intrinsic › increase in › anti-XIa